Asia Pacific Antidote Market Size & Outlook, 2023-2030

The antidote market in Asia Pacific is expected to reach a projected revenue of US$ 704.4 million by 2030. A compound annual growth rate of 8.4% is expected of Asia Pacific antidote market from 2024 to 2030.
Revenue, 2023 (US$M)
$400.5
Forecast, 2030 (US$M)
$704.4
CAGR, 2024 - 2030
8.4%
Report Coverage
Asia Pacific

Asia Pacific antidote market highlights

  • The Asia Pacific antidote market generated a revenue of USD 400.5 million in 2023.
  • The market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
  • In terms of segment, chemical antidote was the largest revenue generating type in 2023.
  • Pharmacological antidote is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 400.5 million
Market revenue in 2030USD 704.4 million
Growth rate8.4% (CAGR from 2023 to 2030)
Largest segmentChemical antidote
Fastest growing segmentPharmacological antidote
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationChemical Antidote, Physical Antidote, Pharmacological antidote
Key market players worldwidePfizer Inc, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories, Viatris Inc, Novartis AG ADR, Baxter International Inc, Emergent BioSolutions Inc, Zydus Lifesciences, Fresenius Kabi, Endo Pharmaceuticals


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 18.6% of the global antidote market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 704.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antidote Market Companies

Name Profile # Employees HQ Website

Asia Pacific antidote market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antidote market will help companies and investors design strategic landscapes.


Chemical antidote was the largest segment with a revenue share of 42.9% in 2023. Horizon Databook has segmented the Asia Pacific antidote market based on chemical antidote, physical antidote, pharmacological antidote covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific antidote market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific antidote market databook

  • Our clientele includes a mix of antidote market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific antidote market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific antidote market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific antidote market size, by country, 2018-2030 (US$M)

Asia Pacific Antidote Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific antidote market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more